The elevated miR-221/222 effectively reduced the expression of the target genes P27 and ERα. These findings are supported by another study by Miller et al. [61], revealing that tamoxifen-resistant breast cancer cells display up-regulation of miR-221/222 and significant reductions in p27 levels. This evidence concerns the gene ESR1 and breast carcinoma.